InMed Pharmaceuticals (INM) Return on Capital Employed (QoQ) (2022 - 2026)
InMed Pharmaceuticals (INM) Return on Capital Employed (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,318.00 |
| Dec 31, 2025 | -1,144.00 |
| Sep 30, 2025 | 1,356.00 |
| Jun 30, 2025 | 3,348.00 |
| Mar 31, 2025 | -1,019.00 |
| Dec 31, 2024 | -2,750.00 |
| Sep 30, 2024 | 242.00 |
| Jun 30, 2024 | -2,517.00 |
| Mar 31, 2024 | 896.00 |
| Dec 31, 2023 | 637.00 |
| Sep 30, 2023 | 52.00 |
| Jun 30, 2023 | 3,882.00 |
| Mar 31, 2023 | 1,202.00 |
| Dec 31, 2022 | 5,380.00 |
| Sep 30, 2022 | -1,218.00 |